Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Realgar Indigo naturalis formula for Relapsed Childhood ALL
NCT05682131Phase 4Recruiting
- Sponsor
- Sun Yat-sen Memorial Hospital
- Start
- Sep 2022
- Primary completion
- Sep 2027
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 4 trial of Compound Huangdai Tablet in acute lymphoblastic leukemia (ALL), sponsored by Sun Yat-sen Memorial Hospital. Started Sep 2022; status: recruiting.
02
Drugs
Compound Huangdai Tablet
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT05682131.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05682131.